Artificial intelligence to assess body composition on routine abdominal CT scans and predict mortality in pancreatic cancer–A recipe for your local application TMH Hsu, K Schawkat, SJ Berkowitz, JL Wei, A Makoyeva, K Legare, ... European journal of radiology 142, 109834, 2021 | 29 | 2021 |
Detection of early-stage pancreatic ductal adenocarcinoma from blood samples: results of a multiplex biomarker signature validation study RE Brand, J Persson, SO Bratlie, DC Chung, BW Katona, A Carrato, ... Clinical and translational gastroenterology 13 (3), e00468, 2022 | 23 | 2022 |
Use of ring-enhancement and focal necrosis to differentiate pancreatic adenosquamous carcinoma from pancreatic ductal adenocarcinoma on CT and MRI K Schawkat, LL Tsai, A Jaramillo-Cardoso, SN Paez, JA Moser, ... Clinical Imaging 73, 134-138, 2021 | 7 | 2021 |
Personalized tumor vaccine for pancreatic cancer S Orr, L Huang, J Moser, D Stroopinsky, O Gandarilla, C DeCicco, ... Cancer Immunology, Immunotherapy 72 (2), 301-313, 2023 | 6 | 2023 |
Impact of hemolysis on multi-OMIC pancreatic biomarker discovery to derisk biomarker development in precision medicine studies R Searfoss, P Shah, K Ofori-Mensa, V Bussberg, V Tolstikov, ... Scientific Reports 12 (1), 1186, 2022 | 5 | 2022 |
Project Survival: Engineering a phenomic and artificial intelligence driven precision medicine biomarker pipeline for pancreatic adenocarcinomas EM Grund, MA Kiebish, VR Akmaev, R Sarangarajan, JJ Crowley, ... Cancer Research 79 (13_Supplement), 4945-4945, 2019 | 1 | 2019 |
Minimally invasive resection of duodenal tumors GE Cervoni, T Singer, C Decicco, JF Critchlow, TS Kent, AJ Moser Journal of Visualized Surgery 5, 2019 | 1 | 2019 |
Project Survival®: Discovery of a molecular-clinical phenome biomarker panel to detect pancreatic ductal adenocarcinoma among at risk populations using high-fidelity … EM Grund, AJ Moser, CL DeCicco, NM Chand, GL Perez-Melara, ... Cancer Research 82 (12_Supplement), 5145-5145, 2022 | | 2022 |
1485P Identification of novel protein biomarkers for FOLFIRINOX-based chemotherapy response in advanced pancreatic adenocarcinoma using patient omics and Bayesian AI AJ Moser, M Kiebish, R Sarangarajan, NM Chand, G Miller, L Rodrigues, ... Annals of Oncology 32, S1094, 2021 | | 2021 |
IMMray™ PanCan-d test performance in detecting early stage pancreatic cancer in high risk symptomatic patients D Dierks, A Zandian, T King, R Brand, A Ney, S Pereira, AJ Moser, ... Zeitschrift für Gastroenterologie 59 (08), A 091, 2021 | | 2021 |
Impact of Hemolysis on Multi-OMIC Pancreatic Biomarker Discovery: Derisking Precision Medicine Biomarker Development R Searfoss, P Shah, K Ofori-Mensa, V Bussberg, V Tolstikov, ... | | 2021 |
1547P Project Survival®: High-fidelity longitudinal phenotypic and multi-omic characterization of pancreatic ductal adenocarcinoma (PDAC) for biomarker discovery AJ Moser, MA Kiebish, EM Grund, CL DeCicco, NM Chand, K Schawkat, ... Annals of Oncology 31, S947-S948, 2020 | | 2020 |
Incidental pulmonary embolism in pancreatic ductal adenocarcinoma: Impact of tumor and AJCC stages at initial staging CT K Schawkat, N Tabah, D Tridente, BL Schlechter, T Singer, C Decicco, ... Pancreatology 19 (7), 979-984, 2019 | | 2019 |
The importance of altruism to biomarker development for pancreatic cancer. DHJ Heo, C DeCicco, T Singer, V Vemulapalli, C Yee, MA Kiebish, ... Journal of Clinical Oncology 37 (15_suppl), 11626-11626, 2019 | | 2019 |
197–Robotic Trans-Duodenal Ampullectomy with Reconstruction GE Cervoni, TH Singer, C DeCicco, JF Critchlow, TS Kent, AJ Moser Gastroenterology 156 (6), S-1386, 2019 | | 2019 |